2,3-DIHYDROXYCHOLEST-4-EN-6-ONE
Compound with spectra: 1 MS (GC)
| SpectraBase Compound ID | 5HxApwMWcCC |
|---|---|
| InChI | InChI=1S/C27H44O3/c1-16(2)7-6-8-17(3)19-9-10-20-18-13-23(28)22-14-24(29)25(30)15-27(22,5)21(18)11-12-26(19,20)4/h14,16-21,24-25,29-30H,6-13,15H2,1-5H3/t17-,18+,19-,20+,21+,24?,25?,26-,27-/m1/s1 |
| InChIKey | DHDBOVIXVFKNCT-ZVFBGJCOSA-N |
| Mol Weight | 416.6 g/mol |
| Molecular Formula | C27H44O3 |
| Exact Mass | 416.329045 g/mol |
| Enantiomer InChIKey | DHDBOVIXVFKNCT-YNQNSDATSA-N |
| Copyright | Copyright © 2011-2024 Wiley-VCH GmbH. All Rights Reserved. |
|---|
- (1S,2R,10S,11S,14R,15R)-4,5-dihydroxy-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0(2,7).0(11,15)]heptadec-6-en-8-one
- 17-(1,5-DIMETHYL-HEXYL)-2,3-DIHYDROXY-10,13-DIMETHYL-1,2,3,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-6-O
(2S,3R,6E,8S,9S,10R,13R,14S,17R)-6-hydroxyimino-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-2,3-diol
2-BETA,3-BETA-DIHYDROXY-6-(E)-HYDROXIMINO-CHOLEST-4-ENE
2-ALPHA,3-ALPHA-DIHYDROXY-6-(E)-HYDROXIMINO-CHOLEST-4-ENE
Acetic acid, 17-(1,5-dimethylhexyl)-10,13-dimethyl-6-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene
6-OXOCHOLEST-4-EN-3-YL ACETATE
2-ALPHA-HYDROXY-6-(E)-HYDROXIMINO-CHOLEST-4-EN-3-ONE
3.beta.-Hydroxy-22/23-iodostigmast-4-ene-6,23/22-dione
Ergost-4-ene-3,6-dione, 25-(acetyloxy)-
(3S,6E,8S,9S,10R,13R,14S,17R)-6-hydroxyimino-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol
This compound is available in the following databases:
Mass Spectra of Physiologically Active Substances - including drugs, steroid hormones,and endocrine disruptors 2011
Author: Parr, Maria Kristina; Opfermann, Georg; Schänzer, Wilhelm; Makin, Hugh L. J.
Fast and reliable identification of trace steroids requires an up-to-date library covering most known and newly emerging steroids. It is updated annually. Learn more.